Injection type immunologic adjuvant hydrogel, hydrogel-drug system, preparation method and application

CN120678910AInactive Publication Date: 2025-09-23SUZHOU UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510922954.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-07-04
Publication Date
2025-09-23
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure CN120678910A_ABST
    Figure CN120678910A_ABST
Patent Text Reader

Abstract

The invention relates to an injectable immunologic adjuvant hydrogel, a hydrogel-drug system and a preparation method and application thereof, in particular to a preparation method of an injectable hydrogel capable of improving a tumor immunosuppressive microenvironment and an anti-tumor application of the injectable hydrogel as a drug sustained release system. The hydrogel material is bi-component hydrogel, a component A is a polymer rich in amino groups, a component B is a micromolecular cross-linking agent containing two or more aldehyde groups, after mixing, the amino groups and the aldehyde groups react to form Schiff base bonds to be cross-linked into the hydrogel, and the obtained hydrogel has the characteristic of being injectable after gel forming. The tumor immunosuppressive microenvironment can be directly implanted into a focus site through a common medical syringe, various immune cells can be collected and activated in vivo, and the tumor immunosuppressive microenvironment is effectively improved. When the hydrogel material is injected into a focus part and is combined with radiation therapy, the injectable hydrogel capable of improving the tumor immunosuppressive microenvironment has a remarkable anti-tumor effect.
Need to check novelty before this filing date? Find Prior Art